Company intelligence / Profile preview

TRIAL•IN Pharma

Ownership: Private
Employees: ~20
Development stage: Other

Overview

TRIAL•IN Pharma provides highly personalized guidance to metastatic and brain tumor cancer patients by identifying innovative treatment options—including investigational drugs in global clinical trials—that may extend survival beyond standard protocols. The company leverages deep expertise in oncology literature and maintains strong ties with leading oncologists worldwide to offer hope where standard care has failed. No direct clinical results are reported as the company does not run its own trials.

Therapeutic areas: Oncology
Modalities: Small MoleculesBiologicsMonoclonal AntibodiesInvestigational Agents
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Collaborates with leading oncologists worldwide

Beyond the preview

Go deeper on TRIAL•IN Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRIAL•IN Pharma.

Explore the full profile